跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LERIN leuprorelin (as acetate) 3.6 mg implant pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
LERIN leuprorelin (as acetate) 3.6 mg implant pre-filled syringe
Approved
STANDARD
LERIN leuprorelin (as acetate) 3.6 mg implant pre-filled syringe
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
cf82f7ff44809c56
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
cf82f7ff44809c56
Product Name
LERIN leuprorelin (as acetate) 3.6 mg implant pre-filled syringe
Artg Id
302571
Artg Name
LERIN leuprorelin (as acetate) 3.6 mg implant pre-filled syringe
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2019-07-31
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
cf82f7ff44809c56
Type
Standard
Back to TGA Approvals
